These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23412981)

  • 1. Matrix metalloproteinases-2, -3 and tissue inhibitors of metalloproteinases-1, -2 in placentas from preterm pregnancies and their association with one-carbon metabolites.
    Sundrani D; Chavan-Gautam P; Pisal H; Mehendale S; Joshi S
    Reproduction; 2013 Apr; 145(4):401-10. PubMed ID: 23412981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
    Fortunato SJ; Menon R; Lombardi SJ
    J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-1 and -9 in human placenta during spontaneous vaginal delivery and caesarean sectioning in preterm pregnancy.
    Sundrani DP; Chavan-Gautam PM; Pisal HR; Mehendale SS; Joshi SR
    PLoS One; 2012; 7(1):e29855. PubMed ID: 22253805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the expression of MMPs and TIMPs in preterm placenta and role of CpG methylation in regulating MMP-9 expression.
    Sundrani D; Narang A; Mehendale S; Joshi S; Chavan-Gautam P
    IUBMB Life; 2017 Dec; 69(12):985-993. PubMed ID: 29130646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
    Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M
    PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered metabolism of maternal micronutrients and omega 3 fatty acids epigenetically regulate matrix metalloproteinases in preterm pregnancy: a novel hypothesis.
    Sundrani DP; Chavan Gautam PM; Mehendale SS; Joshi SR
    Med Hypotheses; 2011 Nov; 77(5):878-83. PubMed ID: 21890280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced folate, increased vitamin B(12) and homocysteine concentrations in women delivering preterm.
    Dhobale M; Chavan P; Kulkarni A; Mehendale S; Pisal H; Joshi S
    Ann Nutr Metab; 2012; 61(1):7-14. PubMed ID: 22776827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of placental long chain polyunsaturated fatty acids in preterm deliveries.
    Dhobale MV; Wadhwani N; Mehendale SS; Pisal HR; Joshi SR
    Prostaglandins Leukot Essent Fatty Acids; 2011; 85(3-4):149-53. PubMed ID: 21816593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance between matrix metalloproteinases and their tissue inhibitors in preeclampsia and gestational trophoblastic diseases.
    Rahat B; Sharma R; Bagga R; Hamid A; Kaur J
    Reproduction; 2016 Jul; 152(1):11-22. PubMed ID: 27256632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
    Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of brain-derived neurotrophic factor and tyrosine kinase B receptor in pregnancy.
    Dhobale M; Mehendale S; Pisal H; D'Souza V; Joshi S
    Neuroscience; 2012 Aug; 216():31-7. PubMed ID: 22542551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-2 and MMP-9 and their tissue inhibitor in preterm human milk.
    Lubetzky R; Mandel D; Mimouni FB; Herman L; Reich R; Reif S
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):210-2. PubMed ID: 20531021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation.
    Hatori K; Sasano Y; Takahashi I; Kamakura S; Kagayama M; Sasaki K
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Apr; 277(2):262-71. PubMed ID: 15052653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expressions of MMP-2, MMP-9, and TIMP-2 in placentas from women exposed to lead.
    González-Puebla E; González-Horta C; Infante-Ramírez R; Sanin LH; Levario-Carrillo M; Sánchez-Ramírez B
    Hum Exp Toxicol; 2012 Jul; 31(7):662-70. PubMed ID: 22241630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition.
    Riley SC; Leask R; Denison FC; Wisely K; Calder AA; Howe DC
    J Endocrinol; 1999 Sep; 162(3):351-9. PubMed ID: 10467226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of docosahexaenoic acid on preterm and term placental pro-oxidant/antioxidant balance.
    Stark MJ; Clifton VL; Hodyl NA
    Reproduction; 2013 Sep; 146(3):243-51. PubMed ID: 23813449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases-2, -3 and -9 in human term placenta.
    Demir-Weusten AY; Seval Y; Kaufmann P; Demir R; Yucel G; Huppertz B
    Acta Histochem; 2007; 109(5):403-12. PubMed ID: 17559909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
    Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
    Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.